浙江大学医学院博士研究生导师简介：黄河

　　11.Zhu X, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Zhang J, Ye X, Lin M, Cai Z, Huang H*.Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation. Leuk Res . 37(9): 1046-51. 2013. (IF: 2.764)

　　12.Sheng L, Fu S, Hu Y, Fu H, Huang H*. Rapid mobilization of fully functional natural killer cells into blood by AMD3100. Transfusion. 53(9):2108-1010. 2013. (IF: 3.526)

　　13.Xie W, Zhou D, Hu K, Xiao X, Huang W, He J, Shi J, Luo Y, Zhang J, Lin M, Cai Z, Huang H, Ye X*. Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy. Exp Ther Med. 6(1):109-114. 2013. (IF: 0.344)

　　14.Zhao Y, Huang H, Wei G*. Novel agents and biomarkers for acute lymphoid leukemia. J Hematol Oncol. 6:40. 2013. (IF: 4.458)

　　15.Zhang L, Zheng W, Wang Y, Wang Y, Huang H*. Human bone marrow mesenchymal stem cells support the derivation and propagation of human induced pluripotent stem cells in culture. Cell Reprogram. 15(3):216-223. 2013. (IF2.744)

　　16.Zhou D, Xie W, Hu K, Huang W, Wei G, He J, Shi J, Luo Y, Li L, Zhu J, Zhang J, Lin M, Ye X, Cai Z, Huang H*. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases. Asian Pac J Cancer Prev. 14(2):929-34. 2013. (IF: 1.271)

　　17.Du K, Hu Y, Wu K, Huang H*. Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Clin Transplant. 27(2):E91-E100. 2013. (IF: 1.634)

　　18.Zheng W, Wang Y, Chang T, Huang H*, Yee JK*. Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells. Gene. 519(1):142-9. 2013. (IF: 2.196)

　　19.Xie W, Hu K, Xu F, Zhou D, He J, Shi J, Luo Y, Zhu J, Zhang J, Lin M, Ye X, Huang H, Cai Z*. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Ann Hematol. 92(4): 481-486. 2013. (IF: 2.866)

　　20.Shi J, Meng X, Luo Y, Tan Y, Zhu X, Zheng G, He J, Zheng WY Xie W, Li L, Ye X, Zhang J, Cai Z, Lin M, Huang H*. Clinical characteristics and outcome of isolated extramedullary relapse in acute leukemia after allogeneic stem cell transplantation: a single-center analysis. Leuk Res . 37(4):372-7.2013. (IF: 2.764)

　　21.He J, Zhu L, Ye X, Li L, Zhu J, Zhang J, Xie W, Shi J, Zheng W, Wei G, Sun J, CaiZ, Huang H*. Clinical Characteristics and Prognosis of 23 Patients With

　　Nonleukemic Myeloid Sarcoma. Am J Med Sci. Aug. 2013.(Epub ahead of print) (IF: 1.334)

　　22.Wang C, Xiao H, Ma J, Zhu Y, Yu J, Sun L, Sun H, Liu Y, Jin C, Huang H*. The F-box protein beta-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells. Biochem Biophys Res Commun. 434(4):728-34. 2013. (IF: 2.406)

　　23.Xie W, Zhao Y, Cao L, Huang W, Wang Y, Huang H*. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature.Med Oncol. 29(4):2417-22. 2012. (IF: 2.147)

　　24.Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang L, Zhang L, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H*. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica. 97 (12):1804-1812. 2012. (IF:5.935)

　　25.Hu Y, Gu Y, Cui Q, Fu H, Sheng L, Wu K, Liu L, Fu S, Yu X, Huang H*. Phytohemagglutinin - activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti - CD122 conditioned NOD/SCID mice. Ann Hematol . 91 (11): 1803-1822. 2012. (IF: 2.866)

　　26.Zhu Y, Wang C, Lan J, Yu J, Jin C. & Huang H*. Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis. Exp Cell Res. 318 (18), 2344-2352. 2012. (IF3.557)

　　27.Liu L, Hu K, Wang B, Huang H*,Yu Q*. Mobilization of endogenous stem cells: A new strategy for bone healing. Bone. 51 (3): 633-634. 2012. (IF: 3.823)

　　28.Wu W, Cao L, Li Y, Yu X, Huang H*, He J. Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai-Dorfman disease. Am J Med Sci. 344(2):155-9. 2012. (IF: 1.334)

　　29.Wu K, Luo Y, Liu L, Zhao Y, Hu Y, Tan Y, Lai X , Huang H*. Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review. J Int Med Res . 40:2409-15. 2012. (IF 0.958)

　　30.Wang T, Huang H,CH Tzeng, Wang P, Wu T, Sun J, Tang J, Hu J, Lin S, Kao R*. Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant .18:1939-44. 2012. (IF 3.94)

　　31.Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J*. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant. Biol Blood Marrow Transplant 18:1509-16. 2012. (IF 3.94)

　　32.Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H*. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS One 7(4): e34321. 2012. (IF:3.73)

　　33.Zhang L, Wang Y, Huang H*. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transplant. 26 (4): 511-519. 2012. (IF:1.634)

　　34.Sun J, Wang Z, Luo Y, Tan Y, David S.Allan, Huang H*. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia. Acta Haematol. 127:143-148. 2012. (IF: 0.894)

　　35.Xu Y, Liu L, Zhang L, Fu S, Li R, Hu K and Huang H*.Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. Folia Biol (Praha) . 58(6):221-30. 2012. (IF: 1.219)

　　36.Cao W, Xiao H, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Ye X, Yu X, Lin M, Cai Z, Huang H*. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 18(2): 273-279. 2012. (IF: 3.940)

　　37.Hu Y, LuoY, Tan Y, Shi J, Sheng L, Fu H, Liu L, Xu Y, Wu K, Xiao H, Zhang L, Yu X, Cai Z, Huang H*. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation. Stem Cells Dev. 21: 177-180. 2012. (IF: 4.670)

　　38.Chang T, Zheng W, Tsark W, Bates S, Huang H, Lin R, Yee JK*. Phenotypic rescue of Induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells. 29: 2090-2093. 2011. (IF 7.701)

　　39.Wei G, Ni W, Chiao J, Cai Z, Huang H, Liu D*. A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol, 4: 46. 2011. (IF: 4.458)

　　40.Liu L, Wang Y, Wu K, Fu S, Zhang L, Xu Y, Huang H*. The tyrosine kinase inhibitor nilotinib inhibits proliferation and osteoblast differentiation of human mesenchymal stromal cells. Bone. 49(5):1117-1118. 2011. (IF: 3.823)

　　41.Liu L, Yu Q, Lin J, Lai X, Cao W, Du K, Wang Y, Wu K, Hu Y, Zhang L, Xiao H, Duan Y, Huang H*. Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 20(11):1961-71. 2011. (IF: 2.301)